MARTHA GIBBS: Open Payments
NPI 1376027722 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,159 in 108 payments from 11 companies in 2025. Trend: 2023 $296 · 2024 $659 · 2025 $2,159
Food & beverage: $2,066Education: $93
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $579 |
| Janssen Biotech, Inc. | 16 | $480 |
| Madrigal Pharmaceuticals | 15 | $434 |
| Ardelyx, Inc. | 12 | $259 |
| Aimmune Therapeutics, Inc. | 14 | $232 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
| QOL Medical, LLC | 1 | $43 |
| Celltrion USA Inc. | 1 | $26 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 2 | $12 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, IBSRELA, ZENPEP, LINZESS, SKYRIZI, XIFAXAN.
Industry payments across GA — which companies pay providers there.
